Blueprint Medicines Corp (BPMC)
107.20
+0.20
(+0.19%)
USD |
NASDAQ |
May 03, 16:00
107.20
0.00 (0.00%)
After-Hours: 20:00
Blueprint Medicines Total Liabilities (Quarterly): 918.64M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 918.64M |
| September 30, 2023 | 902.69M |
| June 30, 2023 | 795.32M |
| March 31, 2023 | 806.07M |
| December 31, 2022 | 835.22M |
| September 30, 2022 | 818.08M |
| June 30, 2022 | 444.70M |
| March 31, 2022 | 261.64M |
| December 31, 2021 | 281.49M |
| September 30, 2021 | 230.24M |
| June 30, 2021 | 239.99M |
| March 31, 2021 | 225.37M |
| December 31, 2020 | 248.30M |
| September 30, 2020 | 238.18M |
| June 30, 2020 | 236.09M |
| March 31, 2020 | 230.69M |
| December 31, 2019 | 243.34M |
| September 30, 2019 | 221.58M |
| June 30, 2019 | 214.35M |
| Date | Value |
|---|---|
| March 31, 2019 | 200.45M |
| December 31, 2018 | 121.12M |
| September 30, 2018 | 116.81M |
| June 30, 2018 | 112.18M |
| March 31, 2018 | 93.60M |
| December 31, 2017 | 91.77M |
| September 30, 2017 | 78.88M |
| June 30, 2017 | 70.63M |
| March 31, 2017 | 64.43M |
| December 31, 2016 | 69.72M |
| September 30, 2016 | 70.14M |
| June 30, 2016 | 73.96M |
| March 31, 2016 | 76.35M |
| December 31, 2015 | 34.92M |
| September 30, 2015 | 37.15M |
| June 30, 2015 | 34.62M |
| March 31, 2015 | 31.19M |
| December 31, 2014 | 14.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
214.35M
Minimum
Jun 2019
918.64M
Maximum
Dec 2023
441.68M
Average
248.30M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.051B |
| Apellis Pharmaceuticals Inc | 594.21M |
| Ionis Pharmaceuticals Inc | 2.603B |
| Madrigal Pharmaceuticals Inc | 235.21M |
| Sarepta Therapeutics Inc | 2.263B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.049B |
| Shareholders Equity (Quarterly) | 130.61M |
| Debt to Equity Ratio | 1.828 |
| Current Ratio | 3.761 |
| Net Debt Paydown Yield | -0.36% |